Abstract
The absorption and metabolism of aspirin has been well documented in two relatively recent reviews (Dixon et al., 1963; Smith & Smith, 1966). In the acid environment of the stomach, aspirin is in the un-ionized form and is absorbed through the gastric mucosa as such. But when it gets into the environment of the blood or duodenum, with or without the help of serum esterases, it rapidly hydrolyses into salicylic and acetic acids. This reaction is so complete and prompt that in patients taking therapeutic doses of aspirin for rheumatoid arthritis and having serum salicylate levels of 20–25 mg/100 ml (1.5–1.8 mM), only two 2 mg/100 ml (0.11 mm) is aspirin per se and the rest is in the form of sodium salicylate. Most of the salicylate ion is excreted in the urine as such, and relatively small amounts are converted to products such as glucuronides, salicyluric acid and gentisic acid. A final observation important to this discussion is the fact that 50–80% of the plasma level of aspirin and especially of salicylate ion is loosely bound to albumin, the exact amount bound being directly related to the total plasma level.
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Al-Mondhiry, H., Marcus, A. & Spaet, T. H. (1969). Fedn Proc., 28, 576
Babb, R. R. & Wilbur, R. S. (1969). Calif Med., 110, 440
Clausen, E. & Jensen, K. (1968). Acta path. microbiol. scand. 72, 219
Dawkins, P. P., Mcarthur, J. N. & Smith, M. J. H. (1970). J. Pharm. Pharmac., in the Press
Dixon, A. ST. J., Martin, B. K., Smith, M. J. H. & Wood, P. H. N. (1963). Salicylates. Boston: Little Brown and Company
Farr, R. S., Rodnan, G. P. & Lasser, E. C. (1961). J. clin. Invest., 40, 1037
Farr, R. S., Reid, R. T. & Minden, P. (1966). J. clin. Invest., 45, 1006
Farr, R. S. (1970). J. Allergy, 45, 321
Gilman, A. (1964). Am. J. Med., 36, 167
Giraldo, B., Blumenthal, M. N. & Spink, W. W. (1969). Ann. intern. Med., 71, 479
Grossman, M. I., Matsumoto, K. K. & Lichter, R. J. (1961). Gastroenterology, 40, 383
Hawkins, D., Pinckard, R. N. & Farr, R. S. (1968). Science, N.Y., 160, 780
Hawkins, D., Pinckard, R. N., Crawford, I. P. & Farr, R. S. (1969). J. clin. Invest., 48, 536
Hench, P. K. & Farr, R. S. (1967). Arthritis Rheum., 10, 283
Lasser, E. C., Farr, R. S., Fujimagari, T. & Tripp, W. N. (1962). Am. J. Roentgenol., 87, 338
Minden, P. & Farr, R. S. (1967). Arthritis Rheum., 10, 299
Moore-Robinson, M. & Warin, R. P. (1967). Br. med. J., 4, 262
Pinckard, R. N., Hawkins, D. & Farr, R. S. (1968). Nature, Lond., 219, 68
Pinckard, R. N., Hawkins, D. & Farr, R. S. (1970). Arthritis Rheum., 13, 361
Ram, J. S. & Maurer, P. H. (1957). Arch. Biochem., 72, 119
Reid, Robert T. & Farr, R. S. (1964). Arthritis Rheum., 7, 747
Rodnan, Gerald P., Garver, P. W. & Farr, R. S. (1962). Arthritis Rheum., 5, 361
Samter, M. & Beers, R. F. (1967). J. Allergy, 40, 281
Samter, M. & Beers, R. F. (1968). Ann. intern. Med., 68, 975
Scott, J. T., Porter, I. H., Lewis, S. M. & Dixon, A. ST. J. (1961). Quart. J. Med., 30, 167
Smith, M. J. H. & Smith, Paul K. (1966). The Salicylates. New York, London, Sydney: Interscience
Weigle, W. O. (1967). Natural and Acquired Immunologic Unresponsiveness. Cleveland, New York: The World Publishing Company
Weiss, H. J. (1968). Lancet, 1, 527
Wijnja, L., Snijder, J. A. M., & Niewig, H. O. (1966). Lancet, 2, 768
Wilkinson, P., Jeremy, R., Brooks, F. P. & Hollander, J. L. (1965). Ann. intern. Med., 63, 109
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1971 Institute of Biology Endowment Fund
About this chapter
Cite this chapter
Farr, R.S. (1971). The Capacity of Aspirin to Acetylate Proteins in Vitro and in Vivo. In: Aldridge, W.N. (eds) A Symposium on Mechanisms of Toxicity. Biological Council. Palgrave, London. https://doi.org/10.1007/978-1-349-01085-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-349-01085-1_6
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-01087-5
Online ISBN: 978-1-349-01085-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)